IBDEI1HT ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23879,1,3,0)
 ;;=3^Asthma,Unspec,Uncomplicated
 ;;^UTILITY(U,$J,358.3,23879,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,23879,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,23880,0)
 ;;=J44.9^^107^1196^14
 ;;^UTILITY(U,$J,358.3,23880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23880,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,23880,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,23880,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,23881,0)
 ;;=K21.9^^107^1196^29
 ;;^UTILITY(U,$J,358.3,23881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23881,1,3,0)
 ;;=3^GERD w/o Esophagitis
 ;;^UTILITY(U,$J,358.3,23881,1,4,0)
 ;;=4^K21.9
 ;;^UTILITY(U,$J,358.3,23881,2)
 ;;=^5008505
 ;;^UTILITY(U,$J,358.3,23882,0)
 ;;=N40.1^^107^1196^27
 ;;^UTILITY(U,$J,358.3,23882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23882,1,3,0)
 ;;=3^Enlarged Prostate w/ LUTS
 ;;^UTILITY(U,$J,358.3,23882,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,23882,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,23883,0)
 ;;=L03.818^^107^1196^15
 ;;^UTILITY(U,$J,358.3,23883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23883,1,3,0)
 ;;=3^Cellulitis,Oth Sites
 ;;^UTILITY(U,$J,358.3,23883,1,4,0)
 ;;=4^L03.818
 ;;^UTILITY(U,$J,358.3,23883,2)
 ;;=^5009064
 ;;^UTILITY(U,$J,358.3,23884,0)
 ;;=G47.33^^107^1196^75
 ;;^UTILITY(U,$J,358.3,23884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23884,1,3,0)
 ;;=3^Sleep Apnea,Obstructive
 ;;^UTILITY(U,$J,358.3,23884,1,4,0)
 ;;=4^G47.33
 ;;^UTILITY(U,$J,358.3,23884,2)
 ;;=^332763
 ;;^UTILITY(U,$J,358.3,23885,0)
 ;;=R73.01^^107^1196^44
 ;;^UTILITY(U,$J,358.3,23885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23885,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,23885,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,23885,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,23886,0)
 ;;=R74.8^^107^1196^1
 ;;^UTILITY(U,$J,358.3,23886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23886,1,3,0)
 ;;=3^Abnormal Levels of Serum Enzymes
 ;;^UTILITY(U,$J,358.3,23886,1,4,0)
 ;;=4^R74.8
 ;;^UTILITY(U,$J,358.3,23886,2)
 ;;=^5019566
 ;;^UTILITY(U,$J,358.3,23887,0)
 ;;=R03.0^^107^1196^25
 ;;^UTILITY(U,$J,358.3,23887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23887,1,3,0)
 ;;=3^Elevated BP Reading w/o Diagnosis of HTN
 ;;^UTILITY(U,$J,358.3,23887,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,23887,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,23888,0)
 ;;=Z91.19^^107^1196^51
 ;;^UTILITY(U,$J,358.3,23888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23888,1,3,0)
 ;;=3^Noncompliance w/ Medical Treatment/Regimen
 ;;^UTILITY(U,$J,358.3,23888,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,23888,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,23889,0)
 ;;=E66.01^^107^1196^52
 ;;^UTILITY(U,$J,358.3,23889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23889,1,3,0)
 ;;=3^Obesity,Morbid
 ;;^UTILITY(U,$J,358.3,23889,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,23889,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,23890,0)
 ;;=F43.11^^107^1196^59
 ;;^UTILITY(U,$J,358.3,23890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23890,1,3,0)
 ;;=3^PTSD,Acute
 ;;^UTILITY(U,$J,358.3,23890,1,4,0)
 ;;=4^F43.11
 ;;^UTILITY(U,$J,358.3,23890,2)
 ;;=^5003571
 ;;^UTILITY(U,$J,358.3,23891,0)
 ;;=F43.12^^107^1196^60
 ;;^UTILITY(U,$J,358.3,23891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23891,1,3,0)
 ;;=3^PTSD,Chronic
 ;;^UTILITY(U,$J,358.3,23891,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,23891,2)
 ;;=^5003572
